This is not the most recent version of the article. View current version (1 JUN 2015)

Intervention Protocol

You have free access to this content

Antidepressants for the treatment of depression in patients with cancer

  1. Giovanni Ostuzzi1,*,
  2. Faith Matcham2,
  3. Sarah Dauchy3,
  4. Corrado Barbui1,
  5. Matthew Hotopf4

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 5 MAR 2014

DOI: 10.1002/14651858.CD011006


How to Cite

Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M. Antidepressants for the treatment of depression in patients with cancer (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD011006. DOI: 10.1002/14651858.CD011006.

Author Information

  1. 1

    University of Verona, Department of Public Health and Community Medicine, Section of Psychiatry, Verona, Italy

  2. 2

    King's College London, Department of Psychological Medicine, The Institute of Psychiatry, London, UK

  3. 3

    Gustave Roussy, Chef du Département Interdisciplinaire de Soins de Support, Paris, France

  4. 4

    The Institute of Psychiatry, King's College London, Department of Psychological Medicine, London, UK

*Giovanni Ostuzzi, Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Policlinico "GB Rossi", Piazzale L.A. Scuro, 10, Verona, 37134, Italy. giovanni.ostuzzi@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 5 MAR 2014

SEARCH

This is not the most recent version of the article. View current version (01 JUN 2015)

References

Additional references

Aaronson 1993
  • Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993;85(5):365-75.
Akechi 2008
Altman 1996
Anderson 2000
  • Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology 2000;14(1):3-20.
APA 1980
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III). 3rd Edition. Washington, DC: American Psychiatric Association, 1980.
APA 1987
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). 3rd Edition. Washington, DC: American Psychiatric Association, 1987.
APA 1994
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th Edition. Washington, DC: American Psychiatric Association, 1994.
Arrieta 2013
  • Arrieta O, Angulo LP, Núñez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martínez-López D, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Annals of Surgical Oncology 2013;20(6):1941-8.
Barbui 2001
Barbui 2011
  • Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. British Journal of Psychiatry 2011;198(1):11-16.
Beck 1961
Brenne 2013
Casey 2011
Cella 1993
  • Cella D, Tulsky D, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. Journal of Clinical Oncology 1993;11:570-9.
Colleoni 2000
  • Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000 2000;356(9238):1326-7.
Elbourne 2002
  • Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
Furukawa 2006
  • Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(1):7-10.
Galway 2012
Hamilton 1960
Hart 2012
  • Hart SL, Hoyt MA, Diefenbach M, Anderson DR, Kilbourn KM, Craft LL, et al. Meta-Analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. Journal of the National Cancer Institute 2012;104(13):990-1004.
Henry 1995
Hickie 2011
Higgins 2003
Higgins 2011
  • Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. Chichester: John Wiley & Sons, Ltd, 2011.
Ioannidis 2008
Iovieno 2011
  • Iovieno N, Tedeschini E, Ameral VE, Rigatelli M, Papakostas GI. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials. International Clinical Psychopharmacology 2011;26:69-74.
Irwin 2013
Kim 2010
Laoutidis 2013
Lapidus 2013
  • Lapidus KA, Soleimani L, Murrough JW. Novel glutamatergic drugs for the treatment of mood disorders. Neuropsychiatric Disease and Treatment 2013;9:1101-12. [DOI: 10.2147/NDT.S36689]
Li 2012
Lloyd-Williams 2009
  • Lloyd-Williams M, Shiels C, Taylor F, Dennis M. Depression – an independent predictor of early death inpatients with advanced cancer. Journal of Affective Disorders 2009;113:127-32.
Lopresti 2012
Mitchell 2011
  • Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncology 2011;12:160-74.
Montgomery 1979
Mottram 2009
  • Mottram PG, Wilson K, Strobl JJ. Antidepressants for depressed elderly. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD003491.pub2]
Ng 2011
Onitilo 2006
  • Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. General Hospital Psychiatry 2006;28:396-402.
Oxman 1992
Pilar-Cuéllar 2013
Pinquart 2010
Prieto 2002
  • Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. Journal of Clinical Oncology 2002;20(7):1907-17.
Rayner 2010
Rayner 2011a
  • Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliative Medicine 2011;25(1):36-51.
Rayner 2011b
  • Rayner L, Price A, Hotopf M, Higginson IJ. The development of evidence-based European guidelines on the management of depression in palliative cancer care. European Journal Of Cancer 2011;47:702-12.
Rodin 2007
  • Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK, Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care. The treatment of depression in cancer patients: a systematic review. Supportive Care in Cancer 2007;15(2):123-36.
Rooney 2010
Rooney 2013
Sarubin 2014
Satin 2009
Shelton 2007
Shim 2012
  • Shim EJ, Park JH. Suicidality and its associated factors in cancer patients: results of a multi-center study in Korea. International Journal of Psychiatry in Medicine 2012;43(4):381-403.
Silva de Lima 1999
  • Silva de Lima M, Hotoph M, Wessely S. The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis. Psychological Medicine 1999;29(6):1273-89.
Silva de Lima 2005
  • Silva de Lima M, Moncrieff J, Soares B. Drugs versus placebo for dysthymia. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001130]
Sterne 2000
Walker 2013
  • Walker J, Sawhney A, Holm Hansen C, Ahmed S, Martin P, Symeonides S, et al. Treatment of depression in adults with cancer: a systematic review of randomized controlled trials. Psychological Medicine 2013:1-11.
Ware 1980
  • Ware JB, Brook RH, Williams KN, Stewart AL, Davies-Avery A. Conceptualisation and measurement of health for adults in the health insurance study. Model of Health and Methodology. R-1987/1-HEW. Vol. 1, Santa Monica, California: Rand Corporation, 1980.
Ware 1992
WHO 1978
  • WHO. The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9). Geneva: World Health Organization, 1978.
WHO 1992
  • WHO. The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10). Geneva: World Health Organization, 1992.
Xia 2009
  • Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al. Losing participants before the trial ends erodes credibility of findings. Psychiatric Bulletin 2009;33(7):254-7.
Zigmond 1983